How Effective Are Monoclonal Antibodies in Preventing Infections?
The effectiveness of mAbs like Palivizumab is well-documented. Clinical trials have demonstrated a significant reduction in hospitalization rates due to RSV in infants who receive Palivizumab. While it does not entirely prevent RSV, it mitigates the severity of the disease, thereby lowering the risk of complications.
